Approval · Notice of Compliance 20852 · 2018
MERREM: Notice of Compliance 20852
Issued May 11, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20852
- Date
- May 11, 2018
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in product ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MERREM | 02218488 | Cancelled Post Market |
| MERREM | 02218496 | Cancelled Post Market |
| MERREM (ADD-VANTAGE VIALS) | 02219018 | Cancelled Pre Market |
| MERREM (ADD-VANTAGE VIALS) | 02219026 | Cancelled Pre Market |